bf/NASDAQ:BCYC_icon.png

COM:BICYCLETHERAPEUTICS

Bicycle Therapeutics

  • Stock

USD

Last Close

20.26

22/11 21:00

Market Cap

895.71M

Beta: -

Volume Today

284.35K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.03
-
0.09
214.05%
0.13
43.26%
0.06
48.52%
0.02
62.19%
0.04
44.48%
0.05
28.64%
cash conversion cycle
-399.59
-
cash per share
5.09
-
4.77
6.33%
8.34
74.92%
7.10
14.83%
17.50
146.44%
11.43
34.67%
14.79
29.35%
company equity multiplier
-1.57
-
-1.17
25.46%
1.18
201.14%
1.69
42.78%
1.39
17.92%
1.52
9.43%
1.60
5.84%
days of inventory outstanding
days of payables outstanding
724.85
-
days of sales outstanding
531.73
-
578.65
8.82%
188.97
67.34%
514.06
172.04%
371.65
27.70%
535.20
44.01%
325.26
39.23%
dividend yield
ebit per revenue
-7.87
-
-3.05
61.28%
-1.91
37.47%
-5.00
162.44%
-5.61
12.17%
-8.07
43.78%
-7.04
12.70%
ebt per ebit
1.00
-
1.02
1.85%
1.17
14.73%
1.00
15.16%
1.04
4.82%
0.98
6.16%
0.94
3.66%
effective tax rate
0.00
-
0.02
1,160.38%
0.01
53.77%
0.01
70.04%
0.02
73.52%
0.01
45.07%
-0.01
160.95%
enterprise value multiple
-5.78
-
-4.57
20.98%
-0.53
88.41%
-4.36
722.62%
-17.27
296.31%
-5.26
69.55%
-0.96
81.74%
fixed asset turnover
1.51
-
3.93
159.52%
3.17
19.14%
2.88
9.25%
0.66
77.17%
0.44
32.87%
0.97
120.77%
free cash flow per share
-0.19
-
-2.05
978.48%
-2.73
33.17%
-0.99
63.69%
-0.67
32.31%
-3.54
427.83%
-1.79
49.60%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
0.76
24.36%
interest coverage
-113.70
-
-21.99
80.66%
-34.88
58.64%
-58.21
66.87%
inventory turnover
long term debt to capitalization
0.01
-
0.14
921.16%
0.11
20.10%
0.13
22.20%
0.10
26.16%
net income per ebt
1.00
-
0.98
1.64%
0.99
0.97%
0.99
0.58%
0.98
1.04%
0.99
1.12%
1.01
2.18%
net profit margin
-7.89
-
-3.06
61.21%
-2.22
27.56%
-4.91
121.37%
-5.71
16.36%
-7.79
36.43%
-6.70
14.07%
operating cash flow per share
-0.11
-
-1.96
1,742.97%
-2.59
32.05%
-0.93
64.13%
-0.59
36.47%
-2.90
391.82%
-1.70
41.33%
operating cycle
325.26
-
operating profit margin
-7.87
-
-3.05
61.28%
-1.91
37.47%
-5.00
162.44%
-5.61
12.17%
-8.07
43.78%
-7.04
12.70%
payables turnover
0.50
-
pretax profit margin
-7.90
-
-3.12
60.57%
-2.24
28.25%
-4.98
122.66%
-5.85
17.58%
-7.90
34.92%
-6.64
15.90%
price fair value
-3.38
-
-2.28
32.43%
1.12
148.92%
3.60
222.13%
4.41
22.38%
3.24
26.41%
1.73
46.49%
receivables turnover
0.69
-
0.63
8.11%
1.93
206.22%
0.71
63.24%
0.98
38.32%
0.68
30.56%
1.12
64.54%
return on assets
-0.22
-
-0.27
21.81%
-0.28
3.78%
-0.32
13.96%
-0.14
56.00%
-0.27
97.11%
-0.30
10.55%
return on capital employed
-0.25
-
-0.30
19.10%
-0.26
13.27%
-0.38
45.11%
-0.15
60.70%
-0.33
120.71%
-0.36
10.64%
return on equity
0.34
-
0.31
9.21%
-0.33
204.97%
-0.53
62.71%
-0.19
63.89%
-0.42
115.71%
-0.49
17.01%
total debt to capitalization
-0.07
-
-0.00
99.71%
0.02
9,355.37%
0.14
613.13%
0.11
19.96%
0.14
23.92%
0.11
23.15%

All numbers in USD (except ratios and percentages)